Back to the search results

Ludgerus-Kliniken Münster GmbH-Standort Raphaelsklinik

Loerstraße 23
48143 Münster

Phone: 0251-5007-0
Mail: ed.renaixela@kinilksleahpar.ofni

https://www.raphaelsklinik.de
  • Number of beds: 261
  • Number of specialist departments: 13
  • Number of inpatient cases: 9.961
  • Number of outpatient cases: 15.540
  • Hospital owners: Ludgerus-Kliniken Münster GmbH
  • Type of provider: freigemeinnützig
External comparative quality assurance
Further information
  • External quality assurance according to state law
    No participation
  • Quality of participation in the Disease Management Programme (DMP)
    No participation
Quantity performed 51
Exception? No exception
Quantity performed 2
Exception? No exception
Quantity performed 153
Exception? No exception
Overall result forecast presentation: yes
Quantity performed reporting year: 153
Quantity forecast year: 182
Examination by state associations? yes
Exemption? yes
Result of the examination by the federal state authorities? yes
Transitional arrangement? no
Overall result forecast presentation: no
Quantity performed reporting year: 51
Quantity forecast year: 0
Examination by state associations? no
Exemption? no
Result of the examination by the federal state authorities? no
Transitional arrangement? no
Overall result forecast presentation: no
Quantity performed reporting year: 2
Quantity forecast year: 2
Examination by state associations? no
Exemption? no
Result of the examination by the federal state authorities? no
Transitional arrangement? no
  • Implementation of resolutions of the Federal Joint Committee on quality assurance (G-BA)
    No participation
  • Clarifying chat completed: no
  • Clarifying chat not completed: no
  • No participation in clarifying chat: no
  • Notification of non-fulfilment of nursing care not made: no
Number Group
72 Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
55 Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
52 Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations
* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”

According to Section 4 (2) of the Quality Management Guideline, facilities must provide for the prevention of and intervention in cases of violence and abuse as part of their internal quality management. The aim is to prevent, recognise and respond appropriately to abuse and violence, particularly against vulnerable patient groups such as children and adolescents or people in need of help, and also to prevent it within the facility. The respective procedure is aligned with the size of the facility, the range of services and the patients in order to define customised solutions for sensitising the teams as well as other suitable preventative and interventional measures. These may include information materials, contact addresses, training/education, codes of conduct, recommendations for action/intervention plans or comprehensive protection concepts.

  • Is a protection concept in place? Yes
Gemäß § 4 Absatz 2 in Verbindung mit Teil B Abschnitt I § 1 der Qualitätsmanagement-Richtlinie haben sich Einrichtungen, die Kinder und Jugendliche versorgen, gezielt mit der Prävention von und Intervention bei (sexueller) Gewalt und Missbrauch bei Kindern und Jugendlichen zu befassen (Risiko- und Gefährdungsanalyse) und – der Größe und Organisationsform der Einrichtung entsprechend – konkrete Schritte und Maßnahmen abzuleiten (Schutzkonzept). In diesem Abschnitt geben Krankenhäuser, die Kinder und Jugendliche versorgen, an, ob sie gemäß § 4 Absatz 2 in Verbindung mit Teil B Abschnitt I § 1 der Qualitätsmanagement-Richtlinie ein Schutzkonzept gegen (sexuelle) Gewalt bei Kindern und Jugendlichen aufweisen.
  • Drug commission
  • Elektronisches Bestellsystem mit der beliefernden Apotheke
  • Spezielle AMTS-Visiten (z. B. pharmazeutische Visiten, antibiotic stewardship, Ernährung)
  • Teilnahme an einem einrichtungsübergreifenden Fehlermeldesystem (siehe Kapitel 12.2.3.2)
  • Aushändigung von arzneimittelbezogenen Informationen für die Weiterbehandlung und Anschlussversorgung der Patientin oder des Patienten im Rahmen eines (ggf. vorläufigen) Entlassbriefs
  • Aushändigung von Patienteninformationen zur Umsetzung von Therapieempfehlungen
  • bei Bedarf Arzneimittel-Mitgabe oder Ausstellung von Entlassrezepten
The instruments and measures to promote drug therapy safety are presented with a focus on the typical procedures of the medication process in inpatient patient care. A special feature of the medication process in the inpatient environment is the transition management during admission and discharge. The instruments and measures listed below address structural elements, e.g. special IT equipment and work materials, as well as process aspects, such as work descriptions for particularly risky process steps or concepts for securing typical risk situations . In addition, proven measures to avoid or learn from medication errors can be specified. The hospital presents here which aspects it has already dealt with and which measures it has specifically implemented. The following aspects can be presented, if necessary using free text fields:
- Admission to hospital, including anamnesis
; Instruments and measures are presented for determining the old medication (drug history), the subsequent clinical assessment and the switch to the medication available in the hospital (house list), as well as for documenting both the patient's original medication and that for hospital treatment adapted medication.
- Medication process in the hospital
In this context, the following sub-processes are assumed as examples: drug history - prescription - patient information - drug delivery - drug use - documentation - therapy monitoring - result assessment. Instruments and measures for safe medication prescription can be presented, e.g. B. in terms of readability, clarity and completeness of the documentation, but also in terms of area of ​​application, effectiveness, benefit-risk ratio, tolerability (including potential contraindications, interactions, etc.) and resource considerations. Information can also be provided to support reliable medication ordering, delivery and use or administration.
- Discharge
In particular, the measures taken by hospitals can be presented to ensure that information on drug therapy is structured and passed on to doctors and physicians providing further treatment, as well as the appropriate provision of patients with drug information, medication plans and medications. Drug prescriptions are made.
AMTS is the totality of measures to ensure an optimal medication process with the aim of reducing medication errors and thus avoidable risks for patients during drug therapy. A prerequisite for the successful implementation of these measures is that AMTS is practised as an integral part of daily routine in an interdisciplinary and multi-professional approach.
Job
Explanation

Prof. Hoffmann: Teilnahme an Studien im Rahmen des Darmkrebs- und Pankreaszentrums

Explanation

PD Dr. Peitz, Prof. Hoffmann, Prof. Kabar, Prof. Lebiedz

Explanation

Explanation

Prof. Hoffmann: Editorial Board Hepatobiliary and Pancreatic Diseases International; PD Dr. Peitz: s. https://www.ncbi.nlm.nih.gov/pubmed/?term=Ulrich+peitz

Explanation

MHH Hannover: Prof. Hoffmann; OVGU Magdeburg: PD Dr. Peitz; WWU Münster: Prof. Kabar, Prof. Lebiedz

Explanation

Famulaturen und PJ sind in allen Kliniken möglich: Lehrvisiten, „Bedside-Teaching“, Röntgen- und Fallbesprechungen, thematisch vielfältige Fortbildungsveranstaltungen, praktische Kurse, Erfahrungen in der Notaufnahme und auf der Intensivstation, Teilnahme an unserem Fort- und Weiterbildungsangebot

Training in other healing professions
Comment

Angebot des praktischen Einsatzes im Bereich der Ausbildung

Comment

Einjährige Ausbildung zur Pflegefachassistenz

Comment

Comment

Zentralschule für Gesundheitsberufe

Comment

Ausbildungsstelle

Comment

in Kooperation mit der FH Münster

Comment

In Kooperation mit dem UKM

Comment

Ausbildungsstelle

Roswitha Zeisberg

Patientenfürsprecherin

Loerstraße 23
48143 Münster

Phone: 0251 -5007-2501
Mail: ed.renaixela@grebsiez.r

Irmela Fluck

Beschwerdemanagement

Loerstraße 23
48143 Münster

Phone: 0251 -976-5858
Mail: ed.renaixela@kculf.i

Irmela Fluck

Qualitäts-Risiko-Beschwerdemanagement

Loerstraße 23
48143 Münster

Phone: 0251 -976-5858
Mail: ed.renaixela@kinilksleahpar.mrq

Dr. Anna Stolze

Leiterin Qualitäts- und Risikomanagement

Loerstraße 23
48143 Münster

Phone: 0251 -976-5800
Mail: ed.renaixela@ezlots.na

Jens Lammers

Leiter Qualitäts- und Risikomanagement

Loerstraße 23
48143 Münster

Phone: 0251 -976-5909
Mail: ed.renaixela@sremmal.snej

Jens Lammers

Leiter Qualitäts- und Risikomanagement

Loerstraße 23
48143 Münster

Phone: 0251 -976-5909
Mail: ed.renaixela@sremmal.snej

Lars Bobe

Leitender Hygienefacharzt

Loerstraße 23
48143 Münster

Phone: 0251 -976-5692
Mail: ed.renaixela@ebob.l

Prof. Dr. med. Peter Feindt

Chefarzt / Thoraxchirurgie

Loerstraße 23
48143 Münster

Phone: 0251 -976-5760
Mail: ed.renaixela@tdnief.p

Prof. Dr. med. Peter Feindt

Chefarzt / Thoraxchirurgie

Loerstraße 23
48143 Münster

Phone: 0251 -976-5760
Mail: ed.renaixela@tdnief.p

Drug commission

Kerstin Haehner

Mitarbeiterin Checkpoint

Loerstraße 23
48143 Münster

Phone: 0251 -5007-2263
Mail: ed.renaixela@renheah.k

Kerstin Haehner

Mitarbeiterin Checkpoint

Loerstraße 23
48143 Münster

Phone: 0251 -5007-2263
Mail: ed.renaixela@renheah.k

Loerstraße 23
48143 Münster

Phone: 0251-5007-0
Mail: ed.renaixela@kinilksleahpar.ofni

Werner Murza

Pflegedirektor

Loerstraße 23
48143 Münster

Phone: 0251 -976-2049
Mail: ed.renaixela@azrum.w

Werner Murza

Pflegedirektor

Loerstraße 23
48143 Münster

Phone: 0251 -5007-2049
Mail: ed.renaixela@azrum.w

Tobias Berse

Kaufmännischer Direktor

Loerstraße 23
48143 Münster

Phone: 0251 -976-2020
Mail: ed.renaixela@esreb.t

Gerold Wolters

Kaufmännischer Direktor

Loerstraße 23
48143 Münster

Phone: 0251 -976-2020
Mail: ed.renaixela@sretlow.g

Gerold Wolters

Kaufmännischer Direktor

Loerstraße 23
48143 Münster

Phone: 0251 -976-2020
Mail: ed.renaixela@sretlow.g

Maik Büscher

Regionalgeschäftsführer

Loerstraße 23
48143 Münster

Phone: 0251 -976-2000
Mail: ed.renaixela@rehcseub.kiam

Maik Büscher

Regionalgeschäftsführer

Loerstraße 23
48143 Münster

Phone: 0251 -976-2000
Mail: ed.renaixela@rehcseub.kiam

Priv.-Doz. Dr. med. Rüdiger Liersch

Ärztlicher Direktor / Chefarzt der Kliniken für Innere Medizin sowie für Hämatologie, Onkologie und Palliativmedizin

Loerstraße 23
48143 Münster

Phone: 0251 -976-2451
Mail: ed.renaixela@hcsreil.r

Prof. Dr. med. Jörn Steinbeck

Ärztlicher Direktor / Chefarzt des Departments für Schulter-, Ellenbogenchirurgie und Sportorthopädie

Loerstraße 23
48143 Münster

Phone: 0251 -5007-2580
Mail: ed.renaixela@kinilksleahpar.ofni

Prof. Dr. med. Jörn Steinbeck

Ärztlicher Direktor / Chefarzt des Departments für Schulter-, Ellenbogenchirurgie und Sportorthopädie

Loerstraße 23
48143 Münster

Phone: 0251 -5007-2580
Mail: ed.renaixela@kinilksleahpar.ofni

No

IK: 260550142

Location number: 773050000

Old location number: 773050000

Hospital portrait for download